PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL)
Clinical trials for PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL) explained in plain language.
Never miss a new study
Get alerted when new PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL) trials appear
Sign up with your email to follow new studies for PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New imaging tracer aims to sharpen picture of Hard-to-Find tumors
Diagnosis Recruiting nowThis study is testing a new imaging agent for PET scans to see if it can find tumors better than the current standard scan. It will involve 40 adults with a rare type of tumor called pheochromocytoma or paraganglioma. Each participant will get both the new and the standard scan s…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL)
Phase: NA • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated Mar 31, 2026 12:11 UTC
-
New scan could spot hidden cancers more clearly
Diagnosis Recruiting nowThis study is testing a new imaging substance called [18F]FAPI-74 to see if it can detect certain cancers better than current standard scans. It will involve 320 adults with one of 10 specific cancer types who are scheduled for treatment. Participants will receive both the new tr…
Matched conditions: PHEOCHROMOCYTOMA/PARAGANGLIOMA (PPGL)
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Mar 23, 2026 15:18 UTC